Although efficient antiviral lamivudine is used for HBVinfected patients, a prolonged treatment with nucleoside analogs often results in lamivudine-resistant variants. In this study, we evaluated the fidelity of the lamivudineresistant variants. The FLAG-tagged wild-type (FPolE) and Met550 variants (FPolE/M550A, M550V, and M550I) of HBV DNA polymerases were expressed in insect cells, then purified. Like many other reverse transcriptases, no 3'→5' exonuclease activity was detected in the HBV DNA polymerase. Since there is no proofreading activity, then the use of the site-specific nucleotide misincorporation method is beneficial. From the f ins value analysis, it is evident that M550I and M550V exhibit higher fidelity values than the wild-type HBV DNA polymerase, while M550A exhibits similar fidelity values. It is therefore suggested that lamivudine resistance comes from the stringency to dNTP binding and the discrimination of dCTP and lamivudine in M550V and M550I.
Introduction
The hepatitis B virus (HBV) is a member of hepadnaviridae, a family of enveloped-hepatotropic DNA viruses. This virus can cause severe liver disease with eventual progression to cirrhosis and primary hepatocellular carcinoma (Beasley et al., 1981; Lok, 2000) . The number of chronic HBV carriers is estimated to exceed 350 million (De Clercq, 1999) . According to the 1997 World Health Organization (WHO) report, HBV chronic infection remains one of the ten most common causes of death worldwide (Ono et al., 2001) .
Unlike most DNA viruses, HBV replicates via reverse transcription of the RNA intermediate. This process includes polymerization of the minus-strand DNA, degradation of the pre-genome from the RNA-DNA heteroduplex, and synthesis of the plus-strand DNA from the minus-strand DNA template. All of the enzyme activities that are responsible for these steps come from the viral DNA polymerase. In general, retroviruses exhibit a relatively high rate of mutation (Preston et al., 1988; Hubner et al., 1992; Yu and Goodman, 1992) . One reason for its low fidelity is that RT lacks 3' to 5' exonuclease activity (Williams and Loeb, 1992; Bakhanashvili et al., 1996) , which is considered to be deficient in HBV. DNA polymerases in other organisms generally have this activity, which removes incorrectly added nucleotides by reorganizing the mismatched base with the template sequence. Low fidelity gives HBV a genomic hypervariability, which is a defense device that allows HBV to escape selection pressures, such as those imposed by the host immune system or drug therapies.
Despite the existence of an effective vaccine, no effective antiviral treatment has been developed for patients that are chronically infected with HBV. Recently, an attractive option became the use of reverse-transcriptase inhibitors as an antiviral drug for hepatitis B (Lai et al., 1998; Dienstag et al., 1999; Jarvis and Foulds, 1999; Santantonio et al., 2000) . Lamivudine, or (-)-β-L-2',3'-dideoxy-3'-thiacytidine (3TC), is a reverse transcriptase inhibitor that has antiviral activity against the human immunodeficiency virus (HIV) (Coates et al., 1992) and HBV. However, it was recently reported that short-term monotherapy is insufficient to clear viral infection, and the prolonged use of lamivudine therapy has caused an increased emergence of lamivudine-resistant HBV (Zoulim, 1999) .
Lamivudine-resistant HBV has isoleucine or valine substitutions for methionine in the YMDD (tyrosine, methionine, and two aspartic acids) motif, which is a highly conserved domain in the RNA-dependent DNA polymerase. It is involved in nucleotide binding in the catalytic site of the *To whom correspondence should be addressed. Tel: 82-2-880-7773; Fax: 82-2-880-7773 E-mail: drjung@snu.ac.kr polymerase (Bartholomew et al., 1997; Allen et al., 1998; Buti et al., 1998) .
In this study, the FLAG-tagged wild-type and lamivudineresistant Met550 variants of HBV polymerases were expressed in insect cells and purified by using immunoaffinity column chromatography. DNA polymerase fidelity was then analyzed to evaluate the relationships between lamivudine resistance and DNA polymerase fidelities.
Materials and Methods
Construction and purification of the wild-type and mutant HBV polymerase Four recombinant plasmids were used as follows: wild-type (pFPolE) and M550 variants (pFPolE/M550A, M550V, M550I) containing the entire HBV polymerase gene (subtype adr) (Rho et al., 1989) , and the catalytic mutant HBV polymerase gene with FLAG sequences at the NH 2 -terminal region. The FLAG tag was used to isolate the wild-type and mutant HBV polymerases. Each recombinant baculovirus was expressed in Sf9 cells. The proteins were purified as described previously (Park and Jung, 2001) . In order to substitute alanine, valine, and isoleucine for methionine, site-directed mutageneses were performed in nucleotides 1648-1650, changing ATG to GCG, GTC and ATA for pFPolE/M550A, M550V, and M550I, respectively (Kim et al., 2001; Park and David, 2002) .
SDS-PAGE and immunoblot analysis
The partially-purified proteins were separated by 7.5% SDS-polyacrylamide gel electrophoresis (PAGE). For the immunoblot analysis, the proteins were electrophoretically transferred to a PVDF blotting membrane. The membranes were probed with a M2 monoclonal antibody and resuspended in PBS containing 0.5% skim milk and 0.3% Tween-20. The immunoblots were then incubated with horseradish peroxidase-conjugated anti-mouse antiserum. The immunoreactive bands were visualized using ECL (Amersham Pharmacia, Buckinghamshire, UK).
DNA polymerase activity
The DNA polymerization reaction (total reaction volume of 50 µl) contained 50 ng of the homopolymer template poly(dA) · oligo(dT) 12-18 (Amersham Pharmacia) , 2 Ci of [α-32 P]dTTP (3,000 Ci/mmol) (NEN Life Science Products, Boston, USA), 50 mM Tris-Cl (pH 7.4), 0.01% NP-40, 10 mM MgCl 2 , 1 mM DTT, 10 mM KCl, and 50 µM unlabeled dTTP. The reaction was started by adding 90 ng (1 pmol) of either the purified proteins of the wild-type or M550 variants, and incubated at 37 o C for 30 min. The reaction was stopped by the addition of 2 µl 0.5 M EDTA. The reaction products were then phenol-extracted and ethanolprecipitated. Two µl of 95% formamide was added and the proteins were immediately denatured by incubating at 95 o C for 3 min, then analyzed by electrophoresis in 7 M urea/16% polyacrylamide gels. Next, the gel was dried and exposed to a phosphoimager system (BAS FLA2000, Fuji, Tokyo, Japan).
Template-primers
To measure the exonuclease activity, the primer (5'-CCCCTAGAAGAAGAAG-3') and template (5'-CGCTA TCCTAAGAAGAAGATCCCC-3') were synthesized for exonuclease activity, and Primer 5385T (5'-TTT TAG ACA GGA ACG GT-3') was used for the site-specific nucleotide mis-insertion. The primers were end-labeled with [γ-32 P]ATP (3000 Ci/mmol) (NEN Life Science Products) using T4 polynucleotide kinase (20 U) (New England Biolabs, Beverly, USA). The reaction was started by adding 100 nM oligonucleotide, incubated at 37 o C for 1.5 h, and stopped by adding EDTA to the final concentration of 20 mM. The reaction mixture was then phenol-extracted twice and ethanol-precipitated. To measure the 3' → 5' exonuclease activity, hybrid molecules between 16-mer oligonucleotide and 24-mer template were made. To measure the site-specific nucleotide misinsertion, 5385T primers were hybridized to the M13mp18 singlestranded template. A partially double-stranded template-primer structure was created by combining the 740 nM 32 P-end-labeled primer with 4 µM template in 50 mM Tris-Cl (pH 7.4), 5 mM MgCl 2 , 2 mM β-mercaptoethanol, and 17 µg BSA. The mixture was heated at 95 o C and allowed to slowly cool to room temperature.
Exonuclease activity The 3' → 5' exonuclease activity was measured by the removal rate of the mismatched 3'-terminal nucleotides from the 5'-[γ-32 P] end-labeled oligonucleotide. The reactions were carried out in a 25 µl reaction mixture containing 300 ng mismatched template-primer, 50 mM Tris-Cl (pH 7.4), 10 mM KCl, 10 mM MgCl 2 , 1 mM DTT, and 0.01% NP-40. The reaction was started by adding 1 pmol FPolE, 100 mU Klenow fragment of E. coli polymerase I as a positive control, or 10 mU HIV-1 RT as a negative control. After incubating for 30 min at 37 o C, the reactions were stopped by adding equal volumes of a formamide dye mix. The mixtures were electrophoresed in 7 M urea/16% polyacrylamide sequencing gels and dried. Lastly, the dried gel was exposed to the phosphoimager system.
Site-specific nucleotide mis-insertion Before measuring the kinetic constants of the correct and incorrect nucleotide incorporation, a time course study was carried out to determine the time frame, while the products were accumulated linearly with time and less than 30% of the original primer was extended (Mendelman et al., 1990) . The reaction time was chosen as 30 min for FPolE, according to the results of the time course experiments (data not shown). The specific activity of the partially-purified enzyme was 40 units/µg (one unit is defined as the amount of enzyme that catalyzes the incorporation of 1 pmol of dTTP into DNA in the poly(dA) n · oligo(dT) 12-18 -directed reaction, 30 min at 37 o C). The reaction was started by combining the 4 µl enzyme-primer-template (12.5 nM FPolE or 5.3 nM HIV-1 RT, 25 µg BSA and 2 µl of the original annealed primer-template solution) and 4 µl dNTP-salts solutions (52 mM Tris-Cl, pH 7.8, 20 mM MgCl 2 , 5 mM DTT, 150 µg BSA, and increasing concentrations of single dNTP). It was then incubated at 37 o C. The reaction was terminated by the addition of EDTA to the final concentration of 50 mM in a 95% formamide buffer. The reaction products were denatured by incubating at 95 o C for 3 min and analyzed by electrophoresis in 7 M urea/16% polyacrylamide gels. An analysis of the deoxynucleotide incorporation assays was done by using a gel based steady-state kinetic assay (Boosalis et al., 1987; Mendelman et al., 1989 Mendelman et al., , 1990 to determine the mis-insertion efficiency for all the mispairs. The gel band intensities of the substrates and products were quantitated using the phosphoimager system within the linear response range.
For each dNTP concentration, the observed rate of deoxynucleotide incorporation (V obs ) was determined by dividing the relative amount of the extended product by the incubation time. The observed rate of deoxynucleotide incorporation was plotted as a function of the dNTP concentration. The data were fitted to the Michaelis-Menten equation using the non-linear least-squares method. Apparent K m and V max steady-state parameters for the incorporation of the correct and incorrect deoxynucleotides were obtained from the fit and used to calculate the frequency of the nucleotide mis-insertion (f ins ) (Randall et al., 1987) .
Results
Construction and purification of FLAG-fused HBV polymerases in insect cells Three single amino acid substitutions were generated at Met550 of this YMDD motif by using site-directed mutagenesis. To express and purify the wild-type (FpolE) and Met550 variants (FpolE/M550A, M550V, M550I), the FLAG-fused HBV polymerases were expressed in insect cells by using the recombinant baculovirus expression system; they were purified using immunoaffinity column containing the M2 monoclonal antibody (Fig. 1) . The enzyme preparations were homogeneous, as judged by Fig. 1 . The protein expression levels, yields, and chromatographic characteristics of the mutant proteins were identical to those of the wild-type enzyme, suggesting that there is no significant change in the overall structure of the mutant enzyme.
The DNA-dependent DNA polymerase activity of the wildtype HBV DNA polymerase and Met550 variants were performed as described in Materials and Methods. Under the standard reaction conditions that are described in Materials and Methods, the polymerase reactions were conducted with the purified fractions of the wild-type or Met550 variants. The polymerase activity of the Met550 variants is 40-60% of the wild-type polymerase (data not shown).
Analysis of the 3' → 5' exonuclease activity All of the reverse transcriptases lacked 3' → 5' exonuclease activity. HBV DNA polymerase, displaying similarities to retroviral transcriptases, was analyzed by its exonuclease activity ( Site-specific nucleotide misincorporation To evaluate the fidelity of the wild-type and mutant HBV DNA polymerases, we used the site-specific nucleotide misincorporation method. The frequency of the nucleotide mis-insertion, f ins, was Fig. 3 . Kinetic assay for site-specific nucleotide mis-insertion. The 5'-[ 32 P] labeled primer 5385T was annealed to a M13mp18 template strand to produce the 3'-terminal mispairs in the presence of increasing concentrations of single dNTP. These are indicated with (A) FpolE, (B) FPolE/M550A, (C) FPolE/M550V, and (D) FPolE/M550I. Gel band intensities of the substrates (Io) and products (I*) were quantitated using the phosphoimager system. The observed rate of deoxynucleotide incorporation (I*/(Io + I*)) was plotted as a function of the dNTP concentration. The data were fitted to the Michaelis-Menten equation using the non-linear least-squares methods.
calculated from the ratio of the insertion efficiency for wrong (W) versus right (R) base pairs, as described in Materials and Methods. The lack of proofreading activity permitted this method. To determine the nucleotide mis-insertion frequency of the wild-type and M550 variants, we measured the V max and K m steady-state parameters for the incorporation of correct and incorrect deoxynucleotides (G, A, T, and C) opposite the T residues on the native M13mp18 template-strand that was primed with the 5'-32 P end-labeled oligonucleotide primers 5385T (Fig. 3) . From the quantitation of the unextended and extended primers from each reaction set, the initial velocities of the product formation were plotted against the dNTP concentrations, and double-reciprocal plots for the initial velocities versus the substrate concentrations were made. Although some of the extended bands (I*) could barely be seen by the naked eye, the scanner that we used was sensitive enough to read the bands. The f ins values for each of the 4 possible insertion events were then derived from the apparent K m and V max kinetic values for each dNTP that was calculated from the double-reciprocal plots. They are summarized in , and those by M550I ranged from 1.04 × 10 −4 to 4.81 × 10 . In the fidelities of each variant, T : G is the smallest and T : T is the biggest, except in M550I. As evident from the f ins value analysis, M550I and M550V have higher fidelities than the wild-type HBV DNA polymerase, and M550A has similar fidelities. 
Discussion
The fidelity of DNA synthesis is a major determinant in generating spontaneous mutation. The frequencies of errors during DNA replication in prokaryotic and eukaryotic cells are between 10 −9 and 10 −10 substitutions per base pair (Echols and Goodman, 1991) . These low mutation rates are achieved by multiple steps in error discrimination. These include base selection by DNA polymerase, 3' → 5' exonucleolytic proofreading, and post-replicative repair (Kunkel, 1992) .
Because all of the reverse transcriptases, including HBV DNA polymerase, lack 3' → 5' proofreading exonuclease activity, then the error-prone mutation rates are 10 . Nucleotide mis-insertion rates are important parameters that contribute to the overall reverse transcriptase fidelity. In the wild-type isolates of HBV, the sequence of the genome may vary up to 10%, despite conservation of the open-reading frame and function (Harrison, 1996) . These genetic variations are possibly related to the infidelity of the HBV DNA polymerase and reverse transcription strategy of HBV. Lamivudine was developed as a potent treatment for HIV infection and has recently been used for HBV-infected patients. Although it has a strong antiviral effect, the emergence of a resistant strain of the virus has been a serious problem (Schuurman et al., 1995) . For HIV, resistance to lamivudine in the cell culture and in vivo correlated with amino acid substitutions in the methionine residue of the YMDD motif of reverse transcriptase. Similar substitutions have also been reported in HBV (Ling et al., 1996; Jardi et al., 1999) . The YMDD motif is a highly-conserved domain in the RNA-dependent DNA polymerases, and it is involved in nucleotide binding in the catalytic site of the polymerase (Jacobo-Molina et al., 1993) . Reportedly, the two aspartic acid residues in this motif, which are highly conserved, are constituted as two of the three in a catalytic triad (JacoboMolina et al., 1993) . In general, two aspartic acid residues of the YMDD motif are generally flanked by hydrophobic residues. In the HIV-1 and HBV mutants, there are valine, isoleucine, leucine, and the alanine substitution of methionine, and these are related to reverse transcriptase fidelity in HIV-1. Valine has a higher fidelity than methionine in HIV-1 and MuLV reverse transcriptase (Pandey et al., 1996; Oude Essink et al., 1997; Hamburg et al., 1998; Kaushik et al., 2000) . The fidelity of the Valine substitution is 1.5 times higher than methionine in the MuLV reverse transcriptase and 3-4.5 times higher than the wild-type methionine in the HIV-1 reverse transcriptase. In the present study, it has 1.46-2.21 times higher fidelity than the wild-type DNA polymerase of HBV.
Isoleucine also has a higher fidelity than methionine in the HIV-1 reverse transcriptase. The fidelity of the Isoleucine substitution is 1.5-6 times higher than methionine in the HIV-1 reverse transcriptase (Pandey et al., 1996; Hamburg et al., 1998) . In the present study, it has 2.72-6.36 times higher fidelity than the wild-type DNA polymerase of HBV. Alanine in the MuLV reverse transcriptase has 1.2 times higher fidelity (Kaushik et al., 2000) .
The Inhibitions of HBV DNA polymerase activity using 5 nucleotide analogs (3TC, FTCTP, ADVDP, PCVTP, LPVTP) show that M550V is 20 times and 15 times more resistant to 3TC and FTCTP, respectively. Also, M550I is 8 times and 20 times more resistant to 3TC and FTCTP, respectively (Das et al., 2001) . In this report, only valine and isoleucine have effective resistance to the nucleotide analog. The other variants (methionine, alanine, lysine, leucine, arginine, and threonine) have little effect. This means that the lamivudine resistance comes from the stringency to dNTP binding and discrimination of dCTP and lamivudine in M550V and M550I. According to Pandey et al. (1996) , the nucleotide selection is related to the structure of the side chain of amino acids. Alanine has the smallest side chain and methionine has the biggest side chain among these four amino acids; therefore, valine and isoleucine may be the proper size. The side chain of a substituent amino acid may prevent or increase the correct alignment of the 3'-O of the primer terminus with the a-phosphate moiety of dNTP. In the case of valine, it has a favorable distance, rather than methionine from the sugar 4.39
Data shown above are the mean values + standard deviation. Standard deviations presented are derived from three independent measurements. The variations were mostly <15%. Mis-insertion frequency, f ins , was evaluated from the ratio of relative V max to K m , using the equation f ins = (V max /K m ) correct /(V max /K m ) incorrect . Fold decrease is the ratio relative to the corresponding template: primer pair for wild-type.
moiety of the primer terminus (Pandey et al., 1996) . An optimal hydrophobic interaction between valine and the sugar moiety may stabilize the template-primer and the interrelateddNTP binding site. Consequently, this would result in a higher fidelity, decrease in affinity, and/or the high K m values for the incorrect nucleotide (Table 1) . Our studies, therefore, indicate that valine and isoleucine at this position play an important role in the fidelity of the DNA synthesis of the enzyme. Lamivudine resistance may also come from this stringency to nucleotide selection in these Met550 variants. Since the present studies only focus on the fidelity of the mis-insertion of the nucleotides on the DNA template, more extensive studies are required to reveal the relationships between the fidelity of the HBV polymerase and genetic variability.
